Biochem Pharma, Inc. v. Emory University
District Court, District of Columbia
1Opinion of the Court
MEMORANDUM OPINION
ROBERTS, District Judge.
Plaintiffs Biochem Pharma, Inc. (“Bio-chem”) and Glaxo Wellcome Inc. (“Glaxo”) and defendant Emory University (“Emory”) are all dissatisfied with the result of an Interference proceeding before the United States Patent and Trademark Office (“USPTO”) Board of Patent Appeals and Interferences (“Board”). Biochem and Glaxo filed this lawsuit seeking review of the Board’s decision. Emory subsequently filed a related lawsuit, Civil Action No. 01-389, seeking review of the same decision. Emory filed in this action a Motion to Dismiss or to Transfer Venue,…
2Cases cited6 opinions
- Stewart Organization, Inc. v. Ricoh Corp.Supreme Court of the United States · 1988
- Van Dusen v. BarrackSupreme Court of the United States · 1964
- Columbia Plaza Corporation v. Security National BankCourt of Appeals for the D.C. Circuit · 1975
- In Re Alan Neal ScottCourt of Appeals for the D.C. Circuit · 1983
- Mylan Pharmaceuticals, Inc. v. HenneyDistrict Court, District of Columbia · 2000
1 more not listed; retrieve them via the Exa API.
3Cited by15 opinions
- Clayton v. District of ColumbiaDistrict Court, District of Columbia · 2014
- Stewart v. O'NEILLDistrict Court, District of Columbia · 2002
- Chang v. United StatesDistrict Court, District of Columbia · 2003
- Holland v. A.T. Massey CoalDistrict Court, District of Columbia · 2004
- Defenders of Wildlife v. JewellDistrict Court, District of Columbia · 2014
10 more not listed; retrieve them via the Exa API.